Editorial Expression of Concern: Clin Rheumatol (2016) 35:205-212
Following receipt of a concern from a reader about this article [1], the Editor-in-Chief is issuing an editorial expression of concern to highlight the large overlap between this article and another article by the same author group [2]. Whilst there is a high percentage of overlap, the Editor-in-Chief considers this article to be sufficiently novel to warrant its inclusion in the scientific record. Jun Iwamoto has not responded to correspondence from the Editor-in-Chief or publisher. The Editor-in-Chief and the publisher were not able to obtain a current email addresses for Mitsuyoshi Uzawa.
References
Iwamoto J, Uzawa M (2016) Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Clinical Rheumatology 35(1): 205–212
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H (2010) Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Therapeutics and Clinical Risk Management 6:593–600
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s10067-014-2812-y
Rights and permissions
About this article
Cite this article
Iwamoto, J., Uzawa, M. Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Clin Rheumatol 40, 3387 (2021). https://doi.org/10.1007/s10067-021-05796-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05796-3